CLOs on the Move

Avitus Orthopaedics

www.avitusortho.com

 
Avitus Orthopaedics is a medical device company developing novel surgical instruments for minimally invasive tissue harvesting. Empower your fusions.
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Boone Drug At New Market

Boone Drug and Healthcare at Deerfield offers a broad range of retail pharmacy, home medical equipment, prosthetic and orthotic goods, home respiratory care, post mastectomy fitters services, enteral therapy services to fill the medical and convalescent

Sagimet

Sagimet Biosciences is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat important diseases such as the liver disease NASH and specific cancers, with focus on targeting dysfunctional metabolic pathways. The company has unique expertise in FASN biology and has created a platform of proprietary FASN inhibitors.

Eurand

Eurand, Inc. is a Yardley, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

SemBioSys Genetics

SemBioSys Genetics is a Calgary, AB-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Apexigen, Inc

Apexigen, Inc. is a privately held biopharmaceutical company discovering and developing innovative antibody therapeutics for the treatment of life-threatening and difficult-to-treat diseases. Using its proprietary antibody technology platform, Apexigen has discovered a pipeline of product candidates, which are currently at varying stages of development. The lead product candidate, APX005M, is a novel immuno-oncology antibody that stimulates and enhances an immune response against cancer. Apexigen is developing other product candidates in partnership with four leading biopharmaceutical companies in China. In addition, Apexigen has formed strategic partnerships with multi-national pharmaceutical companies, including Janssen Biotech, Alcon Laboratories and Toray Industries to discover first-in-class antibody lead candidates for the partners' programs.